Celebration set to commemorate 40th anniversary of the FDA approval of the anti-cancer drug cisplatin
- Jun 22, 2018
- Homepage News, Alumni, Faculty & Staff, Research, Students, Chemistry, College of Natural Science
Please join Michigan State University’s Department of Chemistry on Aug. 3-4, as it celebrates the 40th anniversary of the FDA’s approval of the anti-cancer drug, cisplatin, and showcases some of MSU’s latest cancer research advances in precision nanomedicine, medicinal chemistry and the metabolic regulation of this complex disease.
The two-day event will include a reception and cancer research poster presentation on Friday evening, followed by an all-day symposium on Saturday that features a veritable “Who’s Who” of scientists and experts in the cisplatin/carboplatin field. There will also be presentations from nationally renowned MSU faculty members who will share some of the latest cancer research advances in precision nanomedicine, medicinal chemistry and the metabolic regulation of this complex disease. It’s an event you won’t want to miss!
Cisplatin was discovered at MSU in the mid-to-late 1960s by Barnett Rosenberg and colleagues, Loretta Van Camp and Thomas Krigas. Cisplatin (and the close analog, carboplatin) is known to be the “penicillin of cancer drugs,” because it has been one of the first, most widely prescribed, and most effective treatment for many cancer diagnoses. Cisplatin was approved by the FDA in 1978, revolutionizing the treatment of certain cancers, especially testicular, bladder, lung and stomach cancers, and saving countless lives.
The event is free, however, registration is required. For more information about the event and/or to register, visit https://www.chemistry.msu.edu/cisplatin/.
Banner image: Cisplatin graphic.